Procurement of Nirsevimabum and clesrovimabum solution for injection

Summary

The tender concerns the supply of Nirsevimabum and clesrovimabum solution for injection to the Children’s Clinical University Hospital. A framework agreement of up to EUR 300,000 excluding VAT is planned for 36 months, with a possible extension of up to 12 months. Bidders may submit an offer for one or more product positions or for the full scope, but alternative offers are not allowed. Up to three bidders with the lowest compliant evaluated price may be awarded framework agreement rights for each position. Offers must be submitted electronically by 5 October 2026, prepared in Latvian, and include the participation application, declarations, qualification documents, technical offer and financial offer.